The Curious Case of PHLPP2: More Questions than Answers
PHLPP2's real role in cells remains a mystery despite initial excitement.
Tarik Husremović, Katharina M. Siess, Sumire Antonioli, Vanessa Meier, Lucas Piëch, Irina Grishkovskaya, Nikoleta Kircheva, Silvia E. Angelova, Andreas Brandstätter, Jiri Veis, Fran Miočić-Stošić, Dorothea Anrather, Markus Hartl, Linda Truebestein, Bojan Žagrović, Stephan Hann, Christoph Bock, Egon Ogris, Todor Dudev, Nicholas A.T. Irwin, David Haselbach, Thomas A. Leonard
― 6 min read
Table of Contents
- The Basics of Cell Growth and Growth Factors
- The PIP3 and AKT Connection
- The Role of PTEN
- The PHLPP Family: Anticipation and Disappointment
- The Research Findings
- The Discovery of Pseudophosphatase Nature
- The Evolutionary Context
- The Link to Cancer
- PHLPP's Role in the Cell
- Conclusion
- Original Source
- Reference Links
PHLPP2 is like that one friend who claims to be a fantastic cook but somehow always ends up burning the water. It's known as a pseudophosphatase, meaning it was thought to be able to remove phosphate groups from proteins, a crucial task for many cellular processes. However, it turns out that PHLPP2 might not be cooking up anything after all!
The Basics of Cell Growth and Growth Factors
To understand PHLPP2, we ought to start with cell growth. Our cells are like growing kids; they need the right conditions, friends, and a little guidance to flourish. Growth factors are the wise adults that tell cells when to grow, divide, and mature. They do this by activating some important players on the cell's surface, particularly a group called receptor tyrosine kinases (RTKs).
When growth factors activate RTKs, it's like turning on a switch. This switch causes a chain reaction inside the cell. One of the main characters in this story is Ras, a small GTPase that's essential for transmitting signals. Another player is phosphoinositide 3-kinase (PI3K), which helps convert a specific lipid in the cell membrane into a signaling molecule called PIP3.
AKT Connection
The PIP3 andPIP3 is a bit of a superstar in the cell. It gathers together other proteins that can help control important functions like growth and metabolism. One of its best buddies is Akt, a key player in regulating these processes. Akt gets activated through the help of another protein called PDK1, which phosphorylates it at a specific site.
Thanks to this activation, Akt can help the cell grow, divide, and even manage its energy use, making him a crucial player in keeping everything running smoothly.
PTEN
The Role ofNow, just like in any good story, there's a character who plays the role of the antagonist-enter PTEN. This tumor suppressor acts like a little speed bump, ensuring that things don't get out of hand. It does this by converting PIP3 back into PIP2, thus stopping Akt from going wild in its activities. When PTEN is missing or mutated, the balance is thrown off, leading to potential issues, including cancer.
The PHLPP Family: Anticipation and Disappointment
PHLPP proteins, including PHLPP2, were initially believed to be responsible for deactivating Akt by removing the phosphate groups that keep Akt active. However, new research shows that PHLPP2 may not be performing this task. Instead, it appears to be more like the uncle who shows up at family gatherings but never quite helps with the chores.
The Research Findings
Researchers delving into PHLPP2 found no evidence that this protein could actually remove phosphate groups from Akt. They conducted various experiments, treating purified PHLPP2 with different conditions and found that it didn’t show any of the expected Phosphatase activity. Even when they cranked up the concentration of PHLPP2 to levels much higher than normal, it still didn't show any action.
What's more, traces of other proteins, particularly PP2A, were found contaminating the PHLPP2 samples. It looks like PHLPP2 has been hanging out with the wrong crowd and is often seen being overshadowed by the more potent PP2A.
The Discovery of Pseudophosphatase Nature
Through diligent investigation, scientists concluded that PHLPP2 doesn’t have the active site needed for real phosphatase activity. In simpler terms, it doesn’t have the tools to do the job it was originally thought to do. Some might argue it’s a bit of a fraud, but it seems that PHLPP2 has a role-just not the one we expected.
The findings suggest that PHLPP2 came from an ancestral phosphatase long ago but lost its main function during the course of evolution. In fact, evidence shows that PHLPP is more of a leftover than an active participant in regulating cellular processes.
The Evolutionary Context
Looking back at history, PHLPP2's evolutionary journey suggests that it once had catalytic capabilities, but over time, it lost its ability to perform this function effectively. It's like that athlete who used to dominate the field but ended up on the sidelines after injuries.
Interestingly, PHLPP1 and PHLPP2, two members of the family, emerged after some duplication events in our vertebrate ancestors. Despite their apparent decline in power, they have remained a part of the genetic makeup of many organisms, suggesting they might serve some other purpose, even if we don’t fully understand what that purpose is yet.
The Link to Cancer
The initial excitement about PHLPP proteins, particularly regarding their role in cancer, has dampened considerably. Researchers were hopeful that because they were connected to Akt-known for its role in cancer progression-PHLPP might act as a tumor suppressor.
However, when scientists examined cancer genomics data, they found no significant mutations in PHLPP1 or PHLPP2 associated with cancer. These findings raised many eyebrows, indicating that the role of PHLPP proteins in cancer is overstated, perhaps as exaggerated as a fish tale.
Despite early indications that PHLPP might suppress tumor growth, further studies have shown that knocking out PHLPP2 in mice does not lead to increased cancer risk. In fact, it seems that both PHLPP proteins comfortably co-exist without any significant drama in cancer development.
PHLPP's Role in the Cell
So if PHLPP2 isn’t a player in cancer or a true phosphatase, what does it do? It remains a bit of a mystery. Histories of gene duplication and evolution hint at a potential role that we just haven’t discovered yet.
Perhaps PHLPP2 is still involved in cellular signaling in ways we don’t yet fully understand. Its structures indicate it might bind with certain signaling molecules, like phosphoinositides, hinting that it still has something to offer in the realm of cellular functions.
Many research options loom regarding PHLPP2. Scientists may uncover functions that link this pseudophosphatase to other critical biological pathways, especially considering its expression patterns in various tissues and its potential interactions with other proteins.
Conclusion
In the end, PHLPP2 stands as a reminder of how science is a constantly evolving field. Sometimes, familiar faces turn out to be more complex than they seem or less impactful than they were once thought. PHLPP2 teaches us that the road to discovery is often winding. While it may not be the powerhouse we hoped for, its evolutionary journey and lingering presence in our cells suggest there's still a story to unfold.
As we continue to peel back the layers, who knows what new roles PHLPP2 might reveal? For now, it remains a curious puzzle piece in the grand picture of cellular biology, waiting to find its place in the puzzle.
Title: PHLPP2 is a pseudophosphatase that lost activity in the metazoan ancestor
Abstract: The phosphoinositide 3-kinase (PI3K) pathway is a major regulator of cell and organismal growth. Consequently, hyperactivation of PI3K and its downstream effector kinase, Akt, is observed in many human cancers. PH domain leucine-rich repeat-containing protein phosphatases (PHLPP), two paralogous members of the metal-dependent protein phosphatase family, have been reported as negative regulators of Akt signaling and, therefore, tumor suppressors. However, the stoichiometry and identity of the bound metal ion(s), mechanism of action, and enzymatic specificity of these proteins are not known. Seeking to fill these gaps in our understanding of PHLPP biology, we unexpectedly discovered that PHLPP2 has no catalytic activity against the regulatory phosphorylation sites of Akt, nor the generic substrate para -nitrophenylphosphate. Instead, we found that PHLPP2 is a pseudophosphatase with a single zinc ion bound in its catalytic center. Furthermore, we found that current cancer genomics data do not support the proposed role of PHLPP1 or PHLPP2 as tumor suppressors. Phylogenetic analyses revealed an ancestral phosphatase that arose more than 1 Mya, but that lost activity at the base of the metazoan lineage. In summary, our results provide a molecular explanation for the inconclusive results that have hampered research on PHLPP and argue for a new focus on non-catalytic roles of PHLPP1 and PHLPP2. Significance StatementPHLPP1 and PHLPP2 have previously been reported as protein phosphatases that specifically inactivate Akt, a pro-growth and survival kinase hyperactivated in many human cancers. Unexpectedly, we found that purified PHLPP2 has no detectable enzymatic activity in vitro, an observation which can be rationalized by its unusual active site, which has diverged significantly from that of canonical metal-dependent phosphatases. Furthermore, we show that cancer genomics do not support a role for either PHLPP1 or PHLPP2 in cancer. Our findings argue for the exploration of alternative hypotheses regarding the role of PHLPP in Akt signaling and cancer, with a focus on its non-catalytic functions.
Authors: Tarik Husremović, Katharina M. Siess, Sumire Antonioli, Vanessa Meier, Lucas Piëch, Irina Grishkovskaya, Nikoleta Kircheva, Silvia E. Angelova, Andreas Brandstätter, Jiri Veis, Fran Miočić-Stošić, Dorothea Anrather, Markus Hartl, Linda Truebestein, Bojan Žagrović, Stephan Hann, Christoph Bock, Egon Ogris, Todor Dudev, Nicholas A.T. Irwin, David Haselbach, Thomas A. Leonard
Last Update: 2024-12-04 00:00:00
Language: English
Source URL: https://www.biorxiv.org/content/10.1101/2024.12.03.625870
Source PDF: https://www.biorxiv.org/content/10.1101/2024.12.03.625870.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to biorxiv for use of its open access interoperability.